Breast cancer Trials in Székesfehérvár, Hungary
Conditions / Breast cancer / Székesfehérvár, Hungary
Breast cancer has been the subject of sustained clinical investigation across multiple research sites.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00444587 | A Study of Herceptin (Trastuzumab) in Combination With 2nd-Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer. | COMPLETED | PHASE2 |
| NCT00241449 | A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer | COMPLETED | PHASE3 |
| NCT01081509 | Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment Adherence | COMPLETED | — |
| NCT00091442 | A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer | COMPLETED | PHASE3 |
| NCT01095003 | Trial of Vinflunine Plus Capecitabine in Advanced Breast Cancer | COMPLETED | PHASE3 |
| NCT00102219 | A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast Cancer | COMPLETED | PHASE2 |
| NCT01077154 | Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE) | TERMINATED | PHASE3 |
| NCT01026142 | A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA) | COMPLETED | PHASE3 |
| NCT00099437 | Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy. | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01519700 | Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim | COMPLETED | PHASE3 |